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Major and biologically most explored components of natural organic matter (NOM) are humic acid (HA)
and fulvic acid (FA). We have explored rock shilajit as a source of NOM. On the other hand
carbamazepine (CBZ) is a well known anticonvulsant drug and has a limited accessibility to brain.
Bioavailability and pharmacokinetic proﬁles of CBZ have been improved by complexation and different
techniques also.
Present study has assessed the comparative abilities of FA and HA as complexing agent for CBZ in
order to enhance pharmacokinetic proﬁle of CBZ and accessibility to the brain. These two complexing
agents have been compared on various indices such as their abilities to cause complexation and
enhance solubility, permeability and dissolution. The present study also compared pharmacodynamic
and biochemical proﬁles after oral administration of complexes. With the help of various pharmaceu-
tical techniques such as freeze drying, physical mixture, kneading and solvent evaporation, two molar
ratios (1:1 and 1:2) were selected for complexation and evaluated for conformational analysis
(molecular modeling). Complex formed was further characterized by differential scanning calorimetry
(DSC), Fourier transform infrared spectroscopy (FT-IR), mass spectroscopy and X-ray diffraction (XRD).
Preclinical study on rodents with CBZ–HA and CBZ–FA has yielded appreciable results in terms of
their anticonvulsant and antioxidants activities. However, CBZ–HA (1:2) demonstrated better result
than any other complex.
& 2011 Elsevier B.V. All rights reserved.1. Introduction
Natural Organic Matters more often consist of humic sub-
stances (HS) and non-humic substances. Non-humic substances
are all those materials that can be placed in one of the categories
of discrete compounds such as sugars, amino acids, fats, etc. HSs
are series of relatively high molecular weight, brown to black
colored substances formed by secondary synthetic reactions. HS is
mostly used as a generic name to describe colored material or its
fractions obtained on the basis of solubility characteristics.
Shilajit is a rich source of HS extracted from rocks in many
mountain ranges of the world especially the Himalayas and
Hindukush of the Indian subcontinent [1]. It is a refreshing,
revitalizing agent used in traditional systems of medicine of
many countries including India. Intensive studies during the
1980s have highlighted its constituent components, which pri-
marily comprised of humus (60–80% and including other compo-
nents such as benzoic acid, hippuric acid, fatty acid, ichthyol,ll rights reserved.
x: þ91 11 26059663.ellagic acid, resin, triterpenes, sterol, aromatic carboxylic acid,
3,4-benzocoumarins, amino acids and phenolic lipids). The pre-
sence of a bioactive compound such as dibenzo-alpha-pyrones
along with humic acid (HA) and fulvic acid (FA) (Fig. 1B–C), acting
as carrier molecules for the active ingredients, endows physiolo-
gical properties to shilajit [2,3]. HA (Avg. mol. wt. 6500) is dark
brown to blackish in color, insoluble in water under acidic
conditions but soluble at higher pH values. FA (Avg. mol. wt.
1200) is light yellowish in color, with higher percentage of’
carboxylic groups than HA [4,5], which makes it soluble in water
at any pH value.
Carbamazepine (CBZ) is a well known anticonvulsant agent,
used in the treatment of simple and complex seizures, trigeminal
neuralgia and bipolar affective disorder [6] and is a drug of choice
(Fig. 1A) for simple and complex partial seizures. CBZ is practi-
cally insoluble in water (o200 mg/ml) and lies in class II of
Biopharmaceutical Classiﬁcation System [7] and has a dissolution
rate-limited absorption [8]. It is obtained in four polymorphic
forms, which contribute to its variable absorption proﬁle. Low
aqueous solubility and poor wettability of the drug further
contributes to its unpredicted absorption, which in turn gives
inconsistent bioavailability [9]. CBZ is commonly available in
Fig. 1. Molecular structures of (A) carbamazepine, (B) fulvic acid and (C) humic
acid.
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4–32 h. Thus there are plenty of opportunities to further improve
the dissolution characteristics of CBZ, which may increase the rate
and the extent of absorption and consequently enhance the
therapeutic efﬁcacy. Dissolution characteristics and oral bioavail-
ability may be enhanced by complexing it with a suitable
complexing agent. Thus, the current study attempts to assess
the comparative abilities of FA and HA as complexing agent in
order to enhance the pharmacokinetic proﬁle of CBZ and to
enhance the accessibility to brain.2. Materials and methods
Rock shilajit was obtained and authenticated from Dabur
Research Foundation, Ghaziabad, India. Carbamazepine was pro-
cured as a gift sample from Novartis Pharmaceuticals Ltd., India.
Chemicals and reagents used for the study were of A.R. grade.
2.1. Method for obtaining fulvic and humic acids from rock shilajit
A slightly modiﬁed method that has been previously described
by Ghosal [2] was used to extract FA and HA. The method
consisted of successive extraction of rock and powdered shilajit
with hot organic solvents of increasing polarity to remove the
bioactive components. The residue (marc) was dissolved in 0.1 N
NaOH [10] with intermittent shaking in the presence of nitrogen.
The suspension was ﬁltered and the ﬁltrate was acidiﬁed to a pH
of less than 3 to precipitate out the humic acids. The ﬁltrate was
further shaken with macro-porous ion exchange resin in order to
absorb the FAs, which were then eluted using 0.1 N aqueous
sodium hydroxide solutions.
2.2. Phase solubility behavior and development of complexes
Phase solubility studies were carried out at room temperature
(251) in triplicate according to the method reported by Higuchi
and Conners [11]. Excess amount of carbamazepine was added to
distilled water containing various concentrations (0.2–2% w/v) of
complexing agents (FA and HA) in a series of stopper conical
ﬂasks (100 ml) and shaken for 48 h on a rotary ﬂask shaker. Thesuspensions were passed through membrane ﬁlter (0.45 mm) and
analyzed for carbamazepine using a UV spectroscopy (Shimadzu,
UV 1601) at 285 nm against blanks prepared using the same
concentration of HA/FA in distilled water.2.3. Preparation of the inclusion complexes
Complexes of carbamazepine were prepared with fulvic acid
and humic acid, extracted from shilajit using different techniques
in two different molar ratios 1:1 and 1:2 (drug:complexing
agent). The resulting mass was powdered in a glass mortar and
pestle and passed through a 100-mesh sieve to obtain a uniformly
sized ﬁne powder [12]. Equal amount of drug also underwent the
same process in order to check the process effect.2.3.1. Physical mixture (PM)
Complexes of carbamazepine were prepared by grinding the
mixture for 60 min in a clean dry glass pestle and mortar and the
resulting mass was passed through a 100-mesh sieve to obtain a
uniformly sized ﬁne powder [12].2.3.2. Freeze drying (FD)
Weighed amount of carbamazepine was dissolved in water
using co-solvency (ethanol) and also aqueous solutions of com-
plexing agents were prepared. Both the solutions were mixed and
stirred (200 rpm, 60 min) and then sonicated for an hour. The
solution was frozen for 24 h in a Lyph-lock apparatus and then
freeze dried (Dry winner, DW-8-85 Heto Holten, Denmark) for
12 h. Sucrose solution was (2% w/v) added as a cryoprotectant.
The resulting mass was then powdered in a glass mortar and
pestle and passed through a 100-mesh sieve to obtain the
uniformly sized ﬁne powder [12].2.3.3. Solvent evaporation (SE)
Calculated amount of drug was dissolved in water with the
help of few drops of ethanol and poured into aqueous solution of
HA/FA. The solution was then sonicated for an hour. The obtained
solution was dried in a rotary evaporator under vacuum (Hahn
shin science Co., Hs-2001N, South Korea) and passed through a
100-mesh sieve to obtain the uniformly size ﬁne powder [12].2.3.4. Kneading (KD)
Solid complexes of carbamazepine were also prepared by the
kneading method [12]. Weighed amount of carbamazepine and
HA/FA was triturated for 15 min in a clean dry glass pestle and
mortar. During the trituration process, ethanol was added empiri-
cally to adjust the consistency of the paste. Trituration was
continued until the product started drying on the walls of mortar.
The products were further dried in the hot air oven at 60 1C for
30 min, powdered, passed through a 100-mesh sieve and stored
in desiccators [13].2.4. Characterization of the solid complexes
2.4.1. Differential Scanning Calorimetry (DSC)
For Differential Scanning Calorimetry (DSC) study, samples of
the solid complex, pure drug and FA/HA (10 mg) were taken in a
ﬂat-bottomed aluminum pan and heated over a temperature
range of 30–350 1C at a constant rate of 10 1C/min with purging
of nitrogen (50 ml/min) using alumina as a reference standard in
a differential scanning calorimeter (DSC-7, Perkin Elmer Pyris
6 instrument, USA).
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The FT-IR spectra of carbamazepine, FA/HA and inclusion
complexes were recorded on the Perkin Elmer using the potas-
sium bromide (KBr) disk technique. Five mg of previously dried
sample was mixed with 100 mg KBr and compressed into a pellet
on an IR hydraulic press. Base line was corrected and scanning
was performed at 4000–400 cm1.
2.4.3. Powder X-ray diffraction (XRD)
X-ray diffraction of carbamazepine, FA/HA and their inclusion
complexes was studied using an X-ray diffractometer (PW 1830,
Phillips, Japan). The samples (1000 mg) were rotated during data
collection to reduce orientation effects. PXRD patterns of solid
complex, pure drug and FA were recorded between 2y¼101 and
701 at 35 kV and 30 mA.
2.4.4. Mass spectroscopy
The samples (HA and FA) were dissolved in Milli-Q water to
make a stock of 1 mg/mL and then further dilution was prepared
in Milli-Q water:methanol (50:50). Finally a concentration of
100 ng/mL was prepared and injected into the mass (Snapt Mass
Spectrometry, Q-TOF with UPLC) on electrospray ionization with
positive mode. Capillary, sampling cone and extraction voltages
were 2.51, 21 and 5.3 units, respectively. Source and desolvation
temperatures were 80 and 250 1C, respectively. Nitrogen gas was
used as cone and desolvation gas at 50 and 600 L/h, respectively.
Trap collision energy was used (6.0 units). The system was from
Waters bearing serial no. JAA 272 waters, USA. Software was used
MassLynx V 4.1 waters.
2.5. Conformational analysis by computational method
3D molecular structures were generated and optimized with
Chem 3D-Ultra 8.0 software. While all calculations used are for
geometric optimization, all the energy minimizations were car-
ried out till the RMS gradient is less than 0.08. Optimized
molecular structures and partial atomic charges were used for
the molecular modeling in humic and fulvic acids. H-bonding
analysis was based on ORTEP III [v1.0.3].
2.6. HPLC analysis of carbamazepine in vitro
The concentration of carbamazepine in vitro samples was
determined by validated method [14] using a Shimadzu LC2010
system (Kyoto, Japan) consisting of quaternary LC-10A VP pump,
SPD-10AVP column oven, variable wavelength programmable
UV/VIS detector (285 nm), SCL 10AVP system controller, Rheodyne
injector ﬁtted with a 20 mL loop, degasser and a data processor.
Chromatographic separation was achieved using a LiChrosphers
100 reversed-phase C-18 column (2504.6 mm2), which was
packed with 5 mm particles with a mobile phase consisting of
water and acetonitrile (60:40::water:acetonitrile). The mobile
phase was pumped at a ﬂow rate of 1.0 ml/min at an ambient
temperature (2572 1C). The eluent was monitored by ultraviolet
absorbance at a wavelength of 285 nm with retention times for
CBZ being 4.870.35 min.
2.7. Determination of carbamazepine in complexes
(at equilibrium in water)
Excess amount of complex was kept in amber colored bottles
containing 10 ml of distilled water and stirred on thermostated
mechanical shaker (Grower enterprises, New Delhi, India) at 25 1C
for 5 days. Suspensions were ﬁltered through a 0.22 mm‘‘Millipore’’ ﬁlter, adequately diluted with distilled water and
analyzed by reported HPLC at l¼285 nm [14].
2.8. Release of carbamazepine from complex
Drug release study of API (40 mg CBZ solution) and inclusion
complexes (equivalent to 40 mg CBZ) was performed using USP II
dissolution apparatus (Hanson Research SRS , USA) in 900 mL of
distilled water at 37.570.5 1C (75 rpm, 60 min). The study was
carried out by putting the constituted suspension (5 ml) in
dialysis bag (Spectra-Por dialysis bag, Sigma Aldrich, St. Louis,
MO with cutoff 12,000–14,000 Da). The concentration of the drug
in solution at various time intervals was analyzed by HPLC at
285 nm. All dissolution studies were carried out in triplicate. The
amount of carbamazepine was chosen as per the recommended
dose of the drug [15]. The amount of humic substances present in
a dose of suspension was also within the permissible limit, i.e.
512 mg kg1 body weight [16].
2.9. In vitro everted intestinal sac permeation study
Rats were anesthetized by ether sprinkled onto a piece of
cotton wool in a glass container equipped with a lid. After making
a midline incision in the abdomen, the small intestine was cut at
two positions: at about 18 cm distal to the stomach and at about
30 cm (being the medial jejunum). This segment was then
removed and ligated with silk thread to one end of a glass rod
and carefully everted on the rod, rinsed with saline solution and
then cut and secured to the tip of a 1 ml disposable syringe barrel.
The gut sac was ﬁlled with the modiﬁed KRPB buffer solution and
was then placed inside the bath containing 100 ml of test solution
continuously bubbled (95% O2 and 5% CO2) [17]. After stabiliza-
tion 3 ml (equivalent to about 10 mg drug) CBZ (API), 1:2 freeze
dried (HA and FA complexes) and 1:2 kneading (HA and FA
complexes) complex solution were added into the sac. The tubes
were maintained at 37 1C and shaken continuously at 60 rpm
with bubbling oxygen supply. 100 ml of samples was withdrawn
at an interval of 0, 0.25, 0.5, 1, 2, 4, 8, 12, 24 h from the dissolution
medium and centrifuged at 4000 rpm for 5 min. After ﬁltering
through Millipore ﬁlter (0.45 mm) these were analyzed by HPLC
[14].
2.10. Maximal Electro Seizure (MES) induced convulsion
Swiss albino mice with the average body weight (20–30 g) of
either sex were used for the experiment. Animals were reared in
the Central Animal House for 2 weeks in polypropylene cages and
fed on standard animal feed and water. Dose of CBZ was taken as
per the literature, i.e. 30 mg/kg body weight of mice, which gives
100% protection to animal in MES [18], accordingly dose of
complex was chosen as a fraction of dose of CBZ (i.e. 1/3rd), as
it was evident from the initial experimentations that complexes
were showing 2–3 times better potency than the API alone.
Amount of FA and HA present in dose was also taken to check
the antiepileptic potential of the complexing agent. The animals
were divided into eight groups, i.e. control, CBZ pure, HA, FA, HA–
CBZ complex (1:2 freeze dried, 1:2 kneading) and FA–CBZ com-
plex (1:2 freeze dried, 1:2 kneading) with 6 animals, each with an
average group weight of 25 g. The control and the different
dosages of complexes were given 30 min before the induction of
MES to separate group of mice. Then, the stimulus train was
applied via ear-clip electrode (50 mA, 0.2 s, average voltage
200–250 V) through electroconvulsiometer (Techno India). The
incidence and the duration of extensor tonus were noted. The
duration of seizures (tonic-clonic convulsions) was recorded [19].
Solutions (q.s to 5 ml) of drug and complexes were prepared in
Fig. 2. Phase solubility studies of CBZ with HA and FA at room temperature (25 1C)
in triplicate mode.
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animal experiments were carried out in accordance with Jamia
Hamdard Animal Ethics Committee.
2.11. Ageing study
Freeze dried complexes of humic acid (1:1 and 1:2) and fulvic
acid (1:1 and 1:2) were stored for 6 months in hermitically sealed
containers at room temperature. They were analyzed by TLC for
any ageing affect [20] and compared with fresh samples. Pre-
viously reported [21] mobile phase, ethyl acetate–toluene–
methanol::7.0:2.0:1.0 (v/v) was used for the development of
chromatogram. Precoated silica gel linchosphere aluminum
sheets 60 F254 (20 cm10 cm: 200 mm thickness, E. Merck,
Darmstadt, Germany) were used.
2.12. Picrotoxin induced oxidative stress
2.12.1. Thiobarbituric acid reactive substances (TBARs)
1 ml of suspension medium was taken from the 10% tissue
homogenate. 0.5 ml of 30% TCA was added to it, followed by
0.5 ml of 0.8% TBA reagent. The tubes were then be covered with
aluminum foil and kept in shaking water bath for 30 min at 80 1C.
After 30 min tubes were taken out and kept in ice-cold water for
30 min. Then these were centrifuged at 3000 rpm for 15 min.
The absorbance of the supernatant was read at 540 nm at
room temperature against appropriate blank. Blank consists of
1 ml distilled water, 0.5 ml of 30% TCA and 0.5 ml of 0.8% TBA. The
concentration of MDA will be read from standard curve prepared
using TEP [22].
2.12.2. Tissue glutathione
A 10% tissue homogenate of brain was prepared in 0.02 M
EDTA and 4 ml of cold distilled water was added to it. It was
mixed well with intermittent shaking for 10 min using vortex
mixer and the contents will then be transferred to centrifuge
tubes (rinsed in EDTA) and centrifuged at 6000 rpm for 15 min.
After that, 2 ml of supernatant was mixed well with 4 ml of tris
buffer (0.4 M, pH 8.9) and 0.1 ml of 0.01 M DTNB was added to it.
The absorbance was read within 5 min of the addition of DTNB at
410 nm against a reagent blank with no homogenate [23].
2.13. Pharmacokinetic study
A total of nine male wistar rats (250–300 g) were taken.
Animals were reared in the Central Animal House in polypropy-
lene cages and fed on standard animal feed and water. Before oral
dosing with CBZ, rats were fasted overnight. A dose equivalent to
5 mg/kg body weight of CBZ was given to rats after dispersing the
API and complexes in glycerin. 0.25 ml of blood sample was
collected from retro-orbital tract at each time point and placed
in a vial containing heparin and kept refrigerated until processing.
Time points selected for sampling were 0.25, 0.5, 0.75,1, 2, 4, 8,
12, 16 and 24 h.
The LC/MS/MS system for blood plasma analysis of carbama-
zepine and its main metabolite carbamazepine 10, 11-epoxide in
rat, described by [24], was used. The method consists of a liquid–
liquid extraction procedure and electrospray UPLC/MS/MS analy-
sis. The chromatographic separation was achieved within 5 min
using an Acquity UPLC BEH C8(2.1100, 1.7 mm) column with a
mobile phase composed of Milli-Q water/acetonitrile/acetic acid
(69.5:30:0.5, v/v/v) at a ﬂow rate of 0.25 ml/min. d10-Carbama-
zepine was used as the internal standard for all compounds.
Analytes were determined by electrospray ionization synapt mass
spectrometry in the positive ion mode. Carbamazepine wasmonitored by scanning m/z 237-194, carbamazepine 10, 11-
epoxide by m/z 253-210 and d10-carbamazepine by m/z 247-
204. The lower limit of quantiﬁcation (LLOQ) was 5 ng/ml for each
analyte based on 0.1 ml aliquots of rat plasma. The extraction
recovery of analytes from rat plasma was over 84.9%. Intra-day
and inter-day assay coefﬁcients of variations were in the range of
3.6–4.5 and 2.0–3.6%, respectively. Linearity was observed over
the range of 5–2000 ng/ml.3. Results and discussion
3.1. Characterization of solid complexes
The phase solubility studies revealed a nonlinear relationship
(Fig. 2) for aqueous drug solubility with increasing concentration
of HS. The curves were characteristic AN type (according to
Higuchi and Connors) with different r2 values. It was 0.864 for
HA–CBZ and 0.916 for FA–CBZ. In both the cases up to the
concentration of 1% w/v of CBZ the relationship was linear but
nonlinear afterwards and more HSs were consumed for the
complexation of CBZ as compared to initial regions. Thus, molar
ratios we opted for complexation were 1:1 and 1:2 for both the
complexing agents (HA and FA).
Another ﬁnding we could conclude from the data is that at
higher concentrations of HS (1–2% w/v), solubility of CBZ exhibits
much variable solubility as the deviations are much noticeable.
Comparing both the complexing agents, HA was showing better
interaction as it was more inclined towards the Y-axis. Better
binding capacity of HA is evident from literature also as it shows
several folds higher binding [25] to model chemicals. Existence of
some other mechanism other than inclusion is also evident from
the data obtained. High molecular weight and basic hydrophobi-
city of humic acids also favor the formation of ‘‘micelle’’-like
structures [5,26] with hydrophilic groups on the water side and
the hydrophobic nucleus useful to give superﬁcial adsorption and,
further, inner absorption of organic moieties [27].
The phase solubility graph was also used to ﬁnd out the
binding constant and Gibb’s free energy [28]. The binding con-
stant was calculated according to the formula Ks¼[slope/
S0(1slope)], where S0 is the solubility of carbamazepine without
humic substances. To check out the spontaneity and the feasi-
bility of the entrapment by thermodynamic approach, changes in
Gibb’s free energy (DG) were calculated (at constant temperature
and pressure). It is the net energy available for useful work.
DG¼2.303RT log[S0/Ss], where, Ss and S0 are the solubility of the
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becomes more negative the reaction becomes more feasible. In
the present case physical phenomenon (inclusion of CBZ into HS)
is assumed to be a process and being evaluated. The binding
constants were found to be 5503.73 (M1) for HA–CBZ complex
and 5410.44 (M1) for FA–CBZ complex. Similarly, DG0s for
different complexes are shown in Table 1.
From the XRD analysis and negative tendencies of DG, it was
evident that the disorder of the system was found to decrease as
the CBZ got entrapped into humic substances. To ﬁnd out the
values of change in disorder, entropy is calculated according to
the formula (DG¼DHTDS). Here, DH is the change in enthalpy
as the CBZ gets into the macromolecule (HA and FA). It was
calculated using van’t Hoff equation. All the thermodynamic
parameters are given in Table 1. From the negative values of
DG, DH and DS we can say that this physical phenomenon
(inclusion of CBZ into humic substances) is spontaneous at low
temperature but nonspontaneous at high temperature.
3.1.1. Differential Scanning Calorimetry (DSC)
DSC of pure carbamazepine shows a sharp exothermic peak
at 189 1C (Fig. 3) and DH of about 156.45 J/g, which is in
accordance with the melting point reported in literature [29].
Fulvic acid shows blunt endotherm and exotherm in the region of
100–200 1C while humic acid shows blunt endotherm and
exotherm in the region of 100–340 1C [30].
In DSC analysis all the methods employed showed the devel-
opment of complexes, except physical mixture (1:1 HA–CBZTable 1























as it form F
complexes
1:1 PM 94.6679.63 648.30716.19 1191.94 145.22 98.49
1:2 PM 102.47710.21 710.0372.17 1238.89 144.29 97.09
1:1 SE 119.3274.19 843.24715.38 1329.05 145.95 97.14
1:2 SE 137.36719.93 985.84719.73 1412.43 144 94.42
1:1 KD 156.6575.01 1138.34721.13 1490.26 111.85 67.80
1:2 KD 187.33713.23 1380.67721.19 1596.18 104.73 60.65
1:1 FD 198.15729.73 1466.43714.2 1629.44 107.54 62.41
1:2 FD 299.6571.35 2268.75729.73 1874.38 107.22 58.71
DG0 is the standard Gibb’s free energy expressed in terms of calorie. DH is the change
develops. All the experiments were carried out in triplicate.
Fig. 3. Representative differential scanning calorimetrcomplex). Disappearance or shifting of peaks of drug was a strong
indication of the formation of complex. In the method of physical
mixture there was not any solution medium that could help drug
molecule get complexed with HS. But it was rigorous trituration
that would have helped in complexation since interaction with
different functional groups to develop complexes has been
established [31]. So, an exotherm was observed in the 1:1 HA–CBZ
complex. Comparing the ratios, 1:2 was more promising as the
thermogram was more linear. This observation was in accordance
with the data obtained from the phase solubility studies (existence
of different mechanisms at higher concentration of complexing
agent). Between different complexing agents, there were no sig-
niﬁcant differences observed by DSC analysis.
3.1.2. Fourier Transforms Infrared Spectroscopy
The FT-IR spectrum shows characteristics peaks of carbama-
zepine (Fig. 4A) peaks at 1752 cm1 (CQO stretching),
3460 cm1 (N–H vibration) and 1550 cm1 (CQC stretching of
phenyl) [29]. FT-IR absorption bands of fulvic acid and humic acid
(4A) extracted from shilajit were found in accordance with those
reported in literature [32]. Interactions of carbonyl peak of
carbamazepine with the carboxylic group of HS, stretching vibra-
tion of N–H (3460 cm1) of CBZ with O–H vibration, were
observed. Oleﬁnic and carbonyl peaks of the drug are widespread
and dispersed indicating weak interaction with similar bands in
the complexing agent (Fig. 4B and C). Peaks of the ﬁngerprint
regions (1300–400 cm1) are more diminished, indicating greater

























as it form FA
complexes
76.4571.21 504.348715.38 1065.40 148.21 102.65
84.472.17 567.1937716.19 1123.99 145.51 99.69
141.3675.21 1017.47721.13 1429.43 148.83 97.71
157.89713.13 1148.142721.19 1494.93 147.05 95.68
123.0579.63 872.7273712.59 1347.28 117.21 74.07
135.674.19 971.9368718.93 1404.80 111.33 68.59
176.7272.02 1296.996714.2 1561.65 104.33 60.82
233.1271.35 1742.846729.73 1725.69 102.34 56.93
in enthalpy, expressed in terms of J/g. DS is the change in entropy as the complex
y proﬁles of CBZ, HA, FA and different complexes.
Fig. 4. (A) FT-IR spectra of CBZ, HA and FA. (B) FT-IR spectra of different HA–CBZ complexes. (C) FT-IR spectra of different FA–CBZ complexes.
Fig. 5. X-ray powder diffraction patterns of drug, HA, FA and different complexes.
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complexes prepared by physical mixture and solvent evaporated,
indicating lesser degree of complexometric interaction. On the
other hand freeze dried and kneading complexes of both the typeswere exhibiting better interaction. Comparing the different ratios,
1:2 ratio complexes were exhibiting more dispersed spectra and
greater degree of interaction; likewise HA complexes were
appearing more promising than FA complexes.
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XRD of carbamazepine shows various peaks at different angles
with most intense peaks at 15.411 (100%) followed by 13.181
(83%), 27.841 (66%), 27.321 (60%) and 27.661 (56%) (Fig. 5),
revealing the crystalline nature of carbamazepine. The X-ray
diffraction patterns of fulvic acid show peaks at angles 391 (90%)
and 471 (100%) but it was more amorphous in nature. Similarly HA
also showed amorphous nature in XRD diffractograms.
In XRD studies, little crystallinity was observed in all the
complexes but it was very less in freeze dried and kneading
complexes for both the complexing agents. Similarity between
different process was also observed when compared different HSs
(HA and FA). Comparing the different ratios, 1:2 ratio turns out to
be a better option since in the better performing processes
(kneading and freeze drying) it was showing lesser crystallinity
and good inclusion of drug molecule.3.1.4. Mass spectroscopy
Results of mass spectrometric analysis also show a satisfactory
result (Fig. 6A and B). Signiﬁcant amount of noises was present in
the spectra that were expected considering the macromolecular
and polyionic nature of the molecules. But spectra from both
types of complexes were funneling some common conclusions.
Spectra were showing peaks of un-complexed drug (m/z 237) at
around 40% of relative intensity. Similarly, unused complexing
agents were also observed (m/z 2406.13 for humic acid and
1220.52 for fulvic acid). Most intense peaks in both the spectra
were around 1:2 complexing ratios. 1:1 ratio was also observed in
both the spectra with appreciable relative intensity. Thus it seemsFig. 6. (A) Mass spectra of fulvic acid–CBZ complex. (B) Representative mass
spectra of humic acid–CBZ complex.from the study that all the complexing agents were not consumed
in the complexation and both 1:1 and 1:2 ratios were generated
from the study. Positive results from other studies indicate that
unconsumed macromolecules were imparting their positive
effects in some other way.
3.2. Conformational analysis by computational method
Molecular modeling has shown that complexes of CBZ–HA
and CBZ–FA are stable. The differences in energy of stabilization
between the two complexes are marginal. It revealed that humic/
fulvic acids have the ability for complexation with carbamazepine.
Intermolecular hydrogen bonds observed contribute to the stability
of the molecule. In the case of carbamazepine as shown in Fig. 7,
amide hydrogen is oriented away from the carbonyl group but is
approaching towards one of the aromatic moieties. Fig. 8 shows the
energy minimized structure of fulvic acid. This structure shows at
least ﬁve intramolecular H-bonds. Three out of ﬁve intramolecular
H-bonds are OHyO type, which means that these are strong
H-bonds. These hydrogen bonds are supposed to increase the
stability of the molecule, while a drug complex optimization with
fulvic acid shows that the carbamazepine is stabilized by a strong
NHyN interaction with fulvic acid (Fig. 9).
Although the exact structure of humic acid is not yet char-
acterized, a probable structure is modeled in this study. Total
potential energies of the humic acid and the drug molecule areFig. 7. Energy minimized structure of carbamazepine.
Fig. 8. Energy optimized structure of fulvic acid.
Fig. 9. Carbamazepine complexed with fulvic acid.
Fig. 10. Energy minimized model of humic acid model.
Fig. 11. Carbamazepine complexed with humic acid.
Fig. 12. (A) Release proﬁle of carbamazepine and FA
M.A. Mirza et al. / Results in Pharma Sciences 1 (2011) 16–26 23compared. Total potential energy of the humic acid using Chem
3D-Ultra 8.0 software comes to around 45.896 kcal/mol
(Fig. 10) while a complex of carbamazepine and humic acid is
stabilized at 22.584 (Fig. 11), which is more stable as CBZ alone.
Energy optimization of carbamazepine resulted in 6.84 kcal/mol.
In this complex H of amide of CBZ has an H-bond with OH of HA.
3.3. Determination of carbamazepine in complexes
(at equilibrium in water)
Carbamazepine is practically insoluble in water, aqueous
saturation solubility of carbamazepine was found to be
12.65 mg/ml. Complexation of carbamazepine greatly increased
the solubility (Table 1). Again by all the methods, freeze drying
turns out to be a better technique and 1:2 ratio a better option. It
was assumed that size of the complexes was less than 0.22 mm as
it was the size of ‘‘Millipore’’ ﬁlter.
Better performance of 1:2 ratios may be credited to the
development of CMC in the aqueous media. Because in a similar
study [33], CMC of humic acid like substances was found to form
micelles at a concentration of 2 g/L. This work also reports the
amount of drug solubilized by per gram of HA like substances,
which is in accordance with our ﬁndings. Here fulvic acid appears
to leave a more pronounced effect on the solubility of the drug.
Humic substances offer both types of interaction like metal ion
interaction due to the presence of various functional groups
and inclusion of hydrophobic moieties [34,35]. Regarding the
different binding capacities of HA in comparison with FA, it is
evident from literature that HA binds the model chemicals more
than FA. There is roughly a tenfold decrease moving from humic
acid samples to fulvic acid samples [25]. But our ﬁnding regarding
the increased solubility of a hydrophobic substance shows a
different result. The reason may be the fact that the sorption/
complexation of humic substances is not its intrinsic property; it
generally depends on pH values [36,37] and on the presence
of other ions [38]. As on different pH ranges these behave
differently.
3.4. Release of carbamazepine from complex
The release proﬁles of pure carbamazepine and complexes,
prepared by different methods studied for 60 min, are shown in
Fig. 12A and B. Active pharmaceutical ingredients have an
intrinsic dissolution rate that is dependent on its solubility and
particle size [39], which was showing 34% in 60 min and attaining
plateau then after. Among all the methods freeze drying and
kneading were performing the best release (80%). Maintaining
the results of previous ﬁndings 1:2 ratio bestowed better. Release
proﬁle of humic acid complex was little better than that of fulvic
acid. Among the different techniques employed the physicalcomplexes. (B) Release proﬁle of HA complexes.
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conclude that better complexing interaction resulted in higher
aqueous concentration in a given time period. The result corro-
borates the data obtained from solubility analysis and different
instrumental analyses (Figs. 3–6).
3.5. Comparison of anticonvulsant activity
From all the previous mentioned studies it was very much
obvious that the complexes developed by kneading and freeze-
drying methods showed promising results. So, these were chosen
for further pharmacodynamic study (Table 2). Study of MES
activity showed that due to complexation there was about three-
fold increase in potency of carbamazepine when compared to pure
drug. All the complexes have shown 75% inhibition to electroshock.
The data obtained in this study are in accordance with previous
ﬁndings and permeation study. FA and HA were also given to mice to
check the antiepileptic potential and found zero inhibition. Thus, our
optimized complexes were exhibiting better performance in crossing
blood brain barrier (BBB), which may be attributed to increased
solubility, passive diffusion gradient and lesser ionic character.
Formation of aggregates in humic material is also well known [40],
which may lead to increased local concentration of drug.
3.6. Permeation study across rat gut sac
The permeability of optimized complexes across gut sac was
signiﬁcantly increased (2.9–3.8 times) as compared to carbama-
zepine suspension in water in 24 h (Fig. 13). The permeation proﬁle
of complex shows two patterns, i.e. in initial 10 h there was a sharp
increase in permeation but after that a plateau was observed.
Considering the permeation of complexes across the intestinal
membrane, two opposing forces (concentration gradient and
aggregation of humic substances) act against each other. The
one that predominates inﬂuences the result. Initially, permeationTable 2
Comparative MES activity of optimized complexes in swiss albino mice.
Substance Dose % Inhibition
Control – 0
CBZ 30 mg/kg body wt. 100
FA 102 mg/kg body wt. 0
HA 550 mg/kg body wt. 0
1:2 KD (HA–CBZ) Eq. to 10 mg/kg body wt. of CBZ 75
1:2 KD (FA–CBZ) Eq. to 10 mg/kg body wt. of CBZ 75
1:2 FD (HA–CBZ) Eq. to 10 mg/kg body wt. of CBZ 75
1:2 FD (FA–CBZ) Eq. to 10 mg/kg body wt. of CBZ 75
Control was given only 0.2 ml of glycerin. HA and FA were dispersed in the same
volume of glycerin.
Fig. 13. Permeation study of carbamazepine and optimized complexes.increased steeply because there was an increasing concentration
gradient across the sac but after sometime (10 h) it attains
plateau, as the gradient falls. In spite of having larger size, HA
was showing a better permeability in both the methods of
complexation because of its structure. In aqueous media HA is
less charged [41] and more hydrophobic [31], which aids in its
permeation across intestinal mucosa.
3.7. Ageing study
After ageing freeze dried complexes of HA–CBZ complex (1:1 and
1:2) and FA–CBZ complex (1:1 and 1:2) showed only single spots.
But the position of spots was variable, which may be due to different
polarities [25] of complexing agents (HA and FA). Pure CBZ showed
the Rf value of 0.5 while the average Rf values for fulvic acid
complexes (1:1 and 1:2) were around 0.6. Average Rf values for
humic acid complexes (1:1 and 1:2) were around 0.45. This study
indicates the stability of developed complexes during the study.
3.8. Biochemical estimations of brain tissues
3.8.1. Thiobarbituric acid reactive substances estimation
TBARS levels were signiﬁcantly elevated in PTX-treated group
(1.1370.064 vs. 4.4970.14) (po0.01). TBARS levels were also
signiﬁcantly elevated in the CBZ treated group. TBARS levels were
signiﬁcantly decreased to the normal in all the groups treated with
the carbamazepine complexes (groups 4–7). {F (8, 45)¼245.21}.
Among the entire complexed groups the TBARS levels were effec-
tively normalized with the CBZ–HA (1:2 KD) treated group (Table 3).
Picrotoxin (PTX) treatment signiﬁcantly enhances the TBARS
level compared with the saline control group. This ﬁnding is in
agreement with earlier ﬁndings, which point to the development
of oxidative stress in epilepsy. Enhanced lipid peroxidation as a
result of oxidative stress produces convulsion, which leads to the
inactivation of glutathione synthase, thus permitting abnormal
build up of excitatory neurotransmitter glutamic acid. CBZ treated
group signiﬁcantly decreased the TBARS level compared to the
PTX group. This decrease in the TBARS levels was further
augmented upon complexation of CBZ with the complexing
agents (HA and FA). Augmented reduction in TBARS level could
be attributed to the enhanced bioavailability of CBZ. This is
consistent with the previous ﬁndings, which reported enhanced
bioavailability upon complexation with humic substances [12].
3.8.2. Tissue glutathione
GSH PTX treatment resulted in signiﬁcant decrease in glu-
tathione level when compared with the saline control group and
CBZ treated group (97.2971.99 vs. 29.2471.12) (po0.01). GSH
levels were signiﬁcantly normalized with the treatment with CBZTable 3
Picrotoxin induced oxidative stress studies of the developed complexes and CBZ.




1. Normal saline (NS, 10 ml/kg, i.p.) 1.1370.064** 97.2971.99**
2. PTX (3.5 mg/kg, s.c) 4.4970.14yy 29.2471.12yy
3. CBZ (30 mg/kg, p.o) 2.170.06** 90.9671.59
4. CBZ–HA (1:2)–KD (30 mg/kg, p.o.) 1.1770.05** 108.9671.86**yy
5. CBZ–FA (1:2)–KD (30 mg/kg, p.o.) 1.3670.03** 99.7971.74**
6. CBZ–HA (1:2)–FD (30 mg/kg, p.o.) 1.5270.05yy 97.8072.26**
7. CBZ–FA (1:2)–FD (30 mg/kg, p.o.) 1.6270.04yy 94.9671.34**
8. HA per se (640 mg/kg body wt.) 1.1270.05 101.6371.40
9. FA per se (335 mg/kg body wt.) 1.1570.07 99.7971.30
HA and FA were also given as control.
Data expressed as MeanSEM, ANOVA followed by Dunnett’s t-test for multiple
comparison, yypo0.01 vs Normal Saline (NS), **po0.01 vs CBZ.
Table 4
Pharmacokinetic proﬁles of pure and complexed carbamazepine.
CBZ 1:2 CBZ–FA FD 1:2 CBZ–HA FD
Cmax (ng/ml) 572.58 762.73 724.51
Tmax (h) 1.5 2.0 2.0
Half life (h) 11.24 11.85 15.75
AUC0t (ng h/ml) 5047.9 8107.2 9183.1
AUC0 i (ng h/ml) 8032.4 10,756.46 14,444.40
Elimination rate constant (h1) 0.034 0.053 0.037
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plexed group, CBZ–HA (1:2 KD) was found to have a better effect
on the normalization of GSH.
PTX treatment leads to signiﬁcant lipid peroxidation, which is
evident from the signiﬁcant increase in the TBAR levels of PTX-
treated group and in turn generation of free radicals, which are
quenched by the glutathione. Thus, GSH levels were signiﬁcantly
lowered in PTX-treated group compared to the normal control
group. CBZ treatment signiﬁcantly restored glutathione level to
near normal. Complexation of CBZ with HA and FA further
enhanced the glutathione level. Among all the groups treated with
CBZ complex, the CBZ–HA groups (kneading or freeze dried) were
found to be much effective in reversing the glutathione level.
This could be as a result of enhanced bioavailability of CBZ due
to complexation. Further there are reports [16] of free radicals
scavenging activity of HA and FA and thus the enhanced anti-
oxidant activity of CBZ complex can also be explained by
synergistic activity of HA and FA.
3.9. Pharmacokinetic study
The pharmacokinetic proﬁles of API and the optimized com-
plexes (FA (1:2) and HA (1:2) freeze dried complexes) are shown in
Fig. 14. Both the complexes were showing better absorption of
carbamazepine than API and are comparable to each other. The
complexes took 30 more minutes to attain Cmax and also the slope
of absorption phase of API was sharper than the complexes. It may
be explained by cogitating over the absorption phase. Till the
attainment of plasma concentration around 570 ng/ml, the slope
was almost the same or complexes were performing somewhat
better. It could be attributed to the passive distribution or inherent
permeability of molecule as was also evident from the mass
spectrometer that some drug molecules were un-entrapped. After
this point the absorption phase arose, but in a staggering fashion.
Here, solubilization effect of humic substance dominates and also
the release of entrapped carbamazepine from the complex shows
its effect to uplift the Cmax. FA complex got some higher jump in
Cmax because of the pH independent solubility. In highly acidic
(stomach) pH humic acid shows lesser solubility than fulvic acid
while at alkaline (intestine) both show nearly the same solubility.
The elimination pattern of pure carbamazepine was obvious and in
accordance with the literature. The elimination of complexes was
showing some sustain release characteristics. Not any major
difference in elimination pattern was observed due to nearly the
same solubility. But the smaller molecular size would have played
a role in the distribution and faster elimination. The standard
deviation bars are omitted from the graph to have a clearFig. 14. Graphical representation of mean plasma concentration of CBZ and
complexes (n¼6) after oral administration.understanding of the pharmacokinetic proﬁle. Other parameters
of pharmacokinetics are given in Table 4.4. Conclusion
The present study demonstrates that both HA and FA have
sufﬁcient potentials to be explored as pharmaceutical excipients
for bioavailability enhancement. Complexation of CBZ with FA
and HA indicates its beneﬁcial effect on enhancing brain perme-
ability, which is presumed to decrease the amount of CBZ taken
per se, and hence reduction of side effects encountered. CBZ–HA
(1:2) complex appeared as the best performing complex in
different in vitro and in vivo studies. Further, since FA and HA
have demonstrated good antioxidant activity, they will take care
of oxidative stress produced in seizures. However, further studies
involving different experimental animals are also needed to make
more conclusive statement on these complexing agents.Acknowledgment
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